The eleventh issue of the Pharmacogenomics and Omics Technologies Journal, Spring 2022

5232022

0 نظر

یازدهمین شماره نشریه فارماکوژنومیک و فناوری های امیکس بهار 1401:درمان COVID-19 مبتنی بر شواهد یا پزشکی شخصی؟

فناوری های امیکس و ژنتیک - درمان COVID-19 مبتنی بر شواهد یا پزشکی شخصی؟ FDA

Responsible director speech
Chief clerk speech
Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans
Pharmacogenetics of Direct Oral Anticoagulants
Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy
Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle
Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study

برچسب ها:

0 your comments

your comments

Name *

Email *

ایمیل شما صحیح نمی باشد

Website *

آدرس وب سایت صحیح نمی باشد

Message *

Send your Comment

About Us

Pharmacogenomics and Omics Technologies Journal published in Persian and English and includes articles related to the field of personalized medicine and interdisciplinary topics.

Hobbyists, researchers and experts can be fully respected and the principles contained in the Guide for Authors, journal articles submitted to the electronic system until after the review, if approved, in turn, is published quarterly. Obviously, the lack of the listed cause rejection or delay in the process of scientific review, publishing articles will be received.

The Last News

...

The eleventh issue of the Pharmacogenomics and Omics Technologies Journal, Spring 2022

0 your comments

تولید محتوا، افزایش بازدید سایت(سئو)،طراحی سایت

Style Switcher

About Us

The Last News

Contact Us